VivaDiag SARS-CoV-2 Ag Rapid Test

These assessments needs to be used as a part of a totally built-in COVID-19 methodology, serving to seek out out these contaminated to cut once more the unfold of the virus. VivaDiag™ SARS-CoV-2 Ag Fast Confirm has ONLY been designed to behave as a supplementary look at for suspected conditions of detrimental coronavirus nucleic acid detection or along with nucleic acid detection all through the analysis of suspected conditions. Outcomes from nucleocapsid protein antigen testing shouldn’t be used because the one precise foundation to diagnose or exclude SARS-CoV-2 (COVID-19) an an an infection or to tell an an an infection standing.

VivaDiag SARS-CoV-2 Ag Fast Confirm is dependent upon immunoassay know-how for the speedy, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human oropharyngeal or nasopharyngeal swab specimens. The look at generates a end consequence inside 15 minutes figuring out folks contaminated with COVID-19 rapidly serving to to comprise the unfold of the virus.

The bundle accommodates all gadgets required together with swab, extraction tube, extraction resolution and lateral circulation look at system. No specialised gear or personnel is required to make the most of this look at. The assessments is also carried out in any setting at any time by educated personnel, i.e for knowledgeable use solely

This lateral circulation Covid-19 Fast Antigen Confirm Instruments is for easy for educated personnel to deal with delivering acceptable outcomes quickly utilizing the oropharyngeal or nasopharyngeal swab specimen.

With the specimen collected insert the swab into the extraction tube filled with extraction resolution. Having eradicated a testing system from the sealed pouch apply three drops of the reply and wait 15 minutes before discovering out the look at, a optimistic or detrimental consequence’s clearly indicated.

This Covid-19 Fast Antigen Confirm Instruments has an regular accuracy of 98.79%, a specificity of 99.12% and a sensitivity of 90.90% offering full assurance of quick, acceptable, dependable outcomes.

VivaDiag SARS CoV 2 Ag Rapid Test — VivaDiag SARS CoV 2 Ag Quick Check out

Precept and meant use

Immupass VivaDiag SARS-CoV-2 Ag Fast Confirm is meant for medical laboratories and healthcare knowledgeable use just for point-of-care testing. Not for at-home testing.

Immupass VivaDiag™ SARS-CoV-2 Ag Fast Confirm is dependent upon immunoassay know-how. Every look at system has one line of anti-SARS coronavirus monoclonal antibody on the detection line (T line) and one line of anti-mouse IgG polyclonal antibody on the same old administration line (C line).

When extracted specimen is added to the specimen accurately, it must react with the labeled antibody to type a flowery, the combination then migrates by the use of the membrane by capillary motion and interacts with the coated anti-SARS coronavirus monoclonal antibody on the detection line. If the specimen accommodates SARS-CoV-2 antigen, the detection line will seem purplish-red indicating the SARS-CoV-2 antigen is optimistic. In one other case, the look at end consequence shall be detrimental. The look at system furthermore accommodates a top quality administration line C which must look purplish-red for all skilled assessments. If the same old administration line C wouldn’t seem, the look at end consequence shall be invalid even when the detection line seems.

Composition

Every look at bundle accommodates: 25 look at gadgets, 25 extraction tubes (prefilled with extraction resolution 300 μL / tube), filtered nozzles, 1 tube stand, 25 sterile swabs and 1 bundle insert.

Supplies required however could not supplied: timer.

Specification

Confirm Precept	Colloidal gold
Pattern Kind	Nasal swab, oropharyngeal swab or nasopharyngeal swab
Pattern Quantity	60 μL
Confirm Time	15 min
Operation Temperature	15-30℃
Storage Temperature	2-30℃
Shelf Life (Unopened)	24 months

SARS-CoV-2 Rapid Antigen Test Nasal
9901-NCOV-03G	Roche Diagnostics	25 Tests/Kit	EUR 112.8

Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)
IOV87952	INVBIO	20T/kit	EUR 46.8
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications.

Accu-Tell COVID-19 IgG/IgM Rapid Test
GEN-B352-20tests	Accu test	20 tests	EUR 283.2
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

Accu-Tell COVID-19 IgG/IgM Rapid Test
GEN-B352-40tests	Accu test	40 tests	EUR 385.2
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

Panbio™ COVID-19 Ag Rapid Test Device
41FK10	Abbott	25 Tests/Kit	EUR 115.2

Dynamiker Monkeypox Virus Ag Rapid Test
DNK-2114-1	Dynamiker Biotechnology	20 tests	EUR 702
Description: The product is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human whole blood, serum, plasma or rash exuudate. The kit is intended for professional use only.

Panbio™ COVID-19 Ag Rapid Test Device (Nasal)
41FK11	Abbott	25 Tests/Kit	EUR 128

Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19

2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma)
GEN-402-25tests	All test	25 tests	EUR 292.8
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

COVID-19 IgG/IgM Rapid Test Kit
UNCOV-20	UnScience	20T/kit	EUR 186

Description: COVID-19 IgG/IgM Rapid Test (Serum/Plasma/Whole Blood) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in serum, plasma, or whole blood. This test consists of two test lines, an IgG line and an IgM line, which is pre-coated with two mouse anti-human monoclonal antibodies separately. During testing, the sample reacts with COVID-19 antigen-coated on conjugated pad. As the complex continues to travel up the strip, the anti-COVID-19 IgM antibodies are bound on the IgM line, and the anti-COVID-19 IgG antibodies are bound on the IgG line. The control(C)line appears when sample has flowed through the strip. The presence of anti-COVID-19 IgM and/or IgG will be indicated by a visible test line in the IgM and IgG region. To serve as a procedural control, the control line should always appear if the test procedure is performed properly and the reagents are working as intended.